blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4062868

EP4062868 - APPLICATION OF ANTIMICROBIAL AGENTS TO MEDICAL DEVICES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.05.2023
Database last updated on 20.07.2024
FormerThe application has been published
Status updated on  26.08.2022
Most recent event   Tooltip20.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
C. R. Bard, Inc.
IP Law Group
1 Becton Drive
Franklin Lakes, NJ 07417 / US
[2022/39]
Inventor(s)01 / Thiagarajan, Giridhar
Salt Lake City, UT, 84105 / US
02 / Amin, Murtaza Yusuf
Farmington, UT, 84025 / US
03 / Matson, Jerrid
Champlin, MN, 55316 / US
 [2022/39]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2022/39]
Application number, filing date22173228.230.03.2016
[2022/39]
Priority number, dateUS201562140206P30.03.2015         Original published format: US 201562140206 P
[2022/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4062868
Date:28.09.2022
Language:EN
[2022/39]
Type: A3 Search report 
No.:EP4062868
Date:21.12.2022
Language:EN
[2022/51]
Search report(s)(Supplementary) European search report - dispatched on:EP18.11.2022
ClassificationIPC:A61F2/06, A61F2/07, A61L27/54, A61L29/02, A61L31/02, A61L31/08, A61L29/06, A61M39/02, A61M39/16, A61M39/22, A61M25/00, A61M25/02, A61L29/10, A61L29/16
[2022/39]
CPC:
A61L29/106 (EP,US); A61L29/06 (EP,US); A61L29/10 (US);
A61L29/16 (EP,US); A61M1/3659 (EP,US); A61M25/0009 (EP,US);
A61M25/0045 (EP,US); A61M39/0247 (EP,US); A61M39/162 (EP,US);
A61M39/22 (EP,US); B29C45/00 (US); B29C70/00 (US);
A61L2300/404 (EP,US); A61M2025/0056 (EP,US); A61M2039/0258 (EP,US);
A61M2039/0273 (EP,US); A61M2039/0285 (EP,US); A61M2207/00 (EP,US);
Y10T29/49885 (US) (-)
C-Set:
A61L29/06, C08L75/04 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/26]
Former [2022/39]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ANWENDUNG VON ANTIMIKROBIELLEN MITTELN AUF MEDIZINISCHEN VORRICHTUNGEN[2022/39]
English:APPLICATION OF ANTIMICROBIAL AGENTS TO MEDICAL DEVICES[2022/39]
French:APPLICATION D'AGENTS ANTIMICROBIENS SUR DES DISPOSITIFS MÉDICAUX[2022/39]
Examination procedure17.01.2023Amendment by applicant (claims and/or description)
23.05.2023Examination requested  [2023/26]
23.05.2023Date on which the examining division has become responsible
Parent application(s)   TooltipEP16774103.2  / EP3273907
Fees paidRenewal fee
13.05.2022Renewal fee patent year 03
13.05.2022Renewal fee patent year 04
13.05.2022Renewal fee patent year 05
13.05.2022Renewal fee patent year 06
13.05.2022Renewal fee patent year 07
21.03.2023Renewal fee patent year 08
20.03.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US4592920  (MURTFELDT ROBERT L [US]) [A] 1-8 * column 2, line 19 - column 3, line 26 * * column 3, lines 47-65 * * column 5, lines 2-6 * * column 6, lines 20-44 * * claims 1-3, 14, 15 *;
 [A]EP0484680  (FURUKAWA ELECTRIC CO LTD [JP]) [A] 1-8 * figures 1-3 * * page 2, lines 3-7, 14-21, 43-57 * * page 3, line 3 - page 4, line 19 * * examples 1, 3, 7-9 * * claims 1-7 *;
 [XI]WO2007017019  (MERCK PATENT GMBH [DE], et al) [X] 1-7 * page 14, lines 7-12 * * page 17, lines 13-30 * [I] 8;
 [A]US2010215643  (CLEVENGER RANDELL [US], et al) [A] 1-8 * paragraphs [0009] , [0 23] , [0 38] , [0 64] , [0 75] , [0 79] * * example 2 * * claims 1, 7, 12, 40, 46, 70, 73, 76 *;
 [X]US2010249927  (YANG CHUNLIN [US], et al) [X] 1-4,6-8 * paragraphs [0005] , [00 6] , [0 20] , [0 21] , [0 26] , [0 34] , [0 43] , [0 44] * * claims 1, 3, 4, 6, 7 *;
 [A]US7820284  (TERRY RICHARD N [US]) [A] 1-8* the whole document *;
 [X]US2013171225  (UHLMANN DONALD R [US], et al) [X] 1-8 * paragraphs [0114] , [ 115] , [ 126] , [ 128] * * table 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.